JP2549794B2 - 肺投与用のシクロスポリン形態 - Google Patents

肺投与用のシクロスポリン形態

Info

Publication number
JP2549794B2
JP2549794B2 JP4060142A JP6014292A JP2549794B2 JP 2549794 B2 JP2549794 B2 JP 2549794B2 JP 4060142 A JP4060142 A JP 4060142A JP 6014292 A JP6014292 A JP 6014292A JP 2549794 B2 JP2549794 B2 JP 2549794B2
Authority
JP
Japan
Prior art keywords
iii
cyclosporine
administration
treatment
particles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP4060142A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0585940A (ja
Inventor
ジョン・モーリー
アンドレアス・ルンメルト
マルティン・リスト
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of JPH0585940A publication Critical patent/JPH0585940A/ja
Application granted granted Critical
Publication of JP2549794B2 publication Critical patent/JP2549794B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C07K7/645—Cyclosporins; Related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP4060142A 1991-03-18 1992-03-17 肺投与用のシクロスポリン形態 Expired - Lifetime JP2549794B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919105705A GB9105705D0 (en) 1991-03-18 1991-03-18 Improvements in or relating to organic compounds
GB9105705 1991-03-18

Publications (2)

Publication Number Publication Date
JPH0585940A JPH0585940A (ja) 1993-04-06
JP2549794B2 true JP2549794B2 (ja) 1996-10-30

Family

ID=10691762

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4060142A Expired - Lifetime JP2549794B2 (ja) 1991-03-18 1992-03-17 肺投与用のシクロスポリン形態

Country Status (29)

Country Link
US (1) US5719123A (cg-RX-API-DMAC7.html)
EP (1) EP0504760B1 (cg-RX-API-DMAC7.html)
JP (1) JP2549794B2 (cg-RX-API-DMAC7.html)
KR (1) KR920017644A (cg-RX-API-DMAC7.html)
AT (1) AT404553B (cg-RX-API-DMAC7.html)
AU (1) AU658172B2 (cg-RX-API-DMAC7.html)
CA (1) CA2063106C (cg-RX-API-DMAC7.html)
CH (1) CH685229A5 (cg-RX-API-DMAC7.html)
CZ (1) CZ281260B6 (cg-RX-API-DMAC7.html)
DE (1) DE4208258B4 (cg-RX-API-DMAC7.html)
DK (1) DK0504760T3 (cg-RX-API-DMAC7.html)
ES (1) ES2093130T3 (cg-RX-API-DMAC7.html)
FI (1) FI921125A7 (cg-RX-API-DMAC7.html)
FR (1) FR2674249A1 (cg-RX-API-DMAC7.html)
GB (2) GB9105705D0 (cg-RX-API-DMAC7.html)
GR (1) GR3021497T3 (cg-RX-API-DMAC7.html)
HU (1) HU208492B (cg-RX-API-DMAC7.html)
IE (1) IE67627B1 (cg-RX-API-DMAC7.html)
IL (1) IL101244A (cg-RX-API-DMAC7.html)
IT (1) IT1255040B (cg-RX-API-DMAC7.html)
LU (1) LU88087A1 (cg-RX-API-DMAC7.html)
MX (1) MX9201141A (cg-RX-API-DMAC7.html)
NO (1) NO310754B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ241975A (cg-RX-API-DMAC7.html)
RU (1) RU2098122C1 (cg-RX-API-DMAC7.html)
SA (1) SA92120536B1 (cg-RX-API-DMAC7.html)
SK (1) SK279576B6 (cg-RX-API-DMAC7.html)
TW (1) TW215901B (cg-RX-API-DMAC7.html)
ZA (1) ZA921987B (cg-RX-API-DMAC7.html)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5837677B2 (ja) * 1981-01-13 1983-08-17 松下電器産業株式会社 誘導加熱調理器
JPH07111905B2 (ja) * 1987-07-23 1995-11-29 株式会社東芝 誘導加熱調理器の負荷適否検知回路
ES2177544T3 (es) * 1992-06-12 2002-12-16 Teijin Ltd Polvo ultrafinno para inhalar y metodo para su preparacion.
US5512269A (en) * 1993-06-09 1996-04-30 Burroughs Wellcome, Co. Method of treating retained pulmonary secretions
PE44995A1 (es) * 1994-01-27 1995-12-18 Schering Corp Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias
WO1998001147A1 (en) * 1996-07-08 1998-01-15 Rhone-Poulenc Rorer Limited Medicinal cyclosporin-a aerosol solution formulation
US6517860B1 (en) 1996-12-31 2003-02-11 Quadrant Holdings Cambridge, Ltd. Methods and compositions for improved bioavailability of bioactive agents for mucosal delivery
US5898028A (en) * 1997-03-20 1999-04-27 Novo Nordisk A/S Method for producing powder formulation comprising an insulin
TW581681B (en) * 1998-02-20 2004-04-01 Nektar Therapeutics Liquid crystal forms of cyclosporin
US20020006901A1 (en) * 1999-02-05 2002-01-17 Aldo T. Iacono Use of aerosolized cyclosporine for prevention and treatment of pulmonary disease
FI20002217L (fi) * 1999-12-30 2001-07-01 Orion Yhtymae Oyj Inhalaatiopartikkelit
FI20010115A0 (fi) * 2001-01-18 2001-01-18 Orion Corp Menetelmä nanopartikkelien valmistamiseksi
RU2203064C2 (ru) * 2001-03-11 2003-04-27 Каменев Виктор Федорович Способ лечения аспириновой бронхиальной астмы
DE60233150D1 (de) * 2001-10-19 2009-09-10 Isotechnika Inc Neue cyclosporin-analoge mikroemulsionsvorkonzentrate
WO2004069223A2 (en) * 2003-02-06 2004-08-19 Cipla Ltd Pharmaceutical compositions comprising immunosuppressants and uses thereof
DK1610878T3 (da) * 2003-02-21 2014-12-01 Univ Bath Fremgangsmåde til fremstilling af partikler
US20050059583A1 (en) * 2003-09-15 2005-03-17 Allergan, Inc. Methods of providing therapeutic effects using cyclosporin components
US20060078623A1 (en) * 2004-08-13 2006-04-13 Emisphere Technologies, Inc. Pharmaceutical formulations containing microparticles or nanoparticles of a delivery agent
US7135455B2 (en) * 2004-11-15 2006-11-14 Allergan, Inc Methods for the therapeutic use of cyclosporine components
US7151085B2 (en) * 2004-11-15 2006-12-19 Allergan, Inc. Therapeutic methods using cyclosporine components
US7827042B2 (en) * 2005-11-30 2010-11-02 The Invention Science Fund I, Inc Methods and systems related to transmission of nutraceutical associated information
US7927787B2 (en) * 2006-06-28 2011-04-19 The Invention Science Fund I, Llc Methods and systems for analysis of nutraceutical associated components
US20070124176A1 (en) * 2005-11-30 2007-05-31 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational and/or control systems and methods related to nutraceutical agent selection and dosing
US10296720B2 (en) * 2005-11-30 2019-05-21 Gearbox Llc Computational systems and methods related to nutraceuticals
US8340944B2 (en) * 2005-11-30 2012-12-25 The Invention Science Fund I, Llc Computational and/or control systems and methods related to nutraceutical agent selection and dosing
US7974856B2 (en) 2005-11-30 2011-07-05 The Invention Science Fund I, Llc Computational systems and methods related to nutraceuticals
US20070124219A1 (en) * 2005-11-30 2007-05-31 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational and/or control systems related to individualized nutraceutical selection and packaging
US20080004905A1 (en) * 2006-06-28 2008-01-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for analysis of nutraceutical associated components
US20070289258A1 (en) * 2006-06-14 2007-12-20 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Individualized pharmaceutical selection and packaging
US8068991B2 (en) * 2005-11-30 2011-11-29 The Invention Science Fund I, Llc Systems and methods for transmitting pathogen related information and responding
US8000981B2 (en) 2005-11-30 2011-08-16 The Invention Science Fund I, Llc Methods and systems related to receiving nutraceutical associated information
US8297028B2 (en) 2006-06-14 2012-10-30 The Invention Science Fund I, Llc Individualized pharmaceutical selection and packaging
US20110145009A1 (en) * 2005-11-30 2011-06-16 Jung Edward K Y Methods and systems related to transmission of nutraceutical associatd information
US20080033763A1 (en) * 2005-11-30 2008-02-07 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems related to receiving nutraceutical associated information
US20070136092A1 (en) * 2005-11-30 2007-06-14 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational and/or control systems related to individualized pharmaceutical and nutraceutical selection and packaging
US20080114577A1 (en) * 2005-11-30 2008-05-15 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational methods and systems associated with nutraceutical related assays
US20070174128A1 (en) * 2005-11-30 2007-07-26 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational and/or control systems related to individualized pharmaceutical and nutraceutical selection and packaging
US20080052114A1 (en) * 2005-11-30 2008-02-28 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational systems and methods related to nutraceuticals
DE102006051512A1 (de) 2005-12-06 2007-06-14 Pari GmbH Spezialisten für effektive Inhalation Pharmazeutische Medikamentenzusammensetzungen mit Cyclosporin
US20070219127A1 (en) * 2006-03-20 2007-09-20 Walt John G Cyclosporin a compositions
EP3521302A1 (en) * 2011-05-27 2019-08-07 Allergan, Inc. A new crystalline form of cyclosporine a, methods of preparation, and methods for use thereof
JO3410B1 (ar) 2011-06-07 2019-10-20 Otsuka Pharma Co Ltd تركيبة أريبيبرازول مجفف بالتبريد
BR112014011768A2 (pt) * 2011-11-15 2017-05-09 Allergan Inc forma 2 de ciclosporina a e método de produção da mesma

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU203564B (en) * 1987-12-21 1991-08-28 Sandoz Ag Process for producing new orthorombos cyclosporin without solvatation
CH679119A5 (cg-RX-API-DMAC7.html) * 1988-05-13 1991-12-31 Sandoz Ag
GB8916901D0 (en) * 1989-07-24 1989-09-06 Sandoz Ltd Improvements in or relating to organic compounds

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
ＥＵＲ．Ｊ．ＰＨＡＲＭＡＣＯＬ．，ＶＯＬ．１８３，ＮＯ．４（１９９０），Ｐ．１１８７−１１８８
Ｊ．ＣＬＩＮ．ＰＨＡＲＭＡＣＯＬ．，ＶＯＬ．２９，ＮＯ．９（１９８９），Ｐ．８６０
Ｊ．ＨＥＡＲＴＴＲＡＮＳＰＬＡＮＴ，ＶＯＬ．９，ＮＯ．１（１９９０），Ｐ．６４
ＬＡＮＣＥＴ，ＶＯＬ．３３９，（１９９２），Ｐ．３２４
ＳＵＲＧＥＲＹ．ＶＯＬ．１０８，ＮＯ．２（１９９０），Ｐ．１９８−２０５

Also Published As

Publication number Publication date
AU1294092A (en) 1992-09-24
FR2674249B1 (cg-RX-API-DMAC7.html) 1995-05-12
HU208492B (en) 1993-11-29
JPH0585940A (ja) 1993-04-06
IE67627B1 (en) 1996-04-17
RU2098122C1 (ru) 1997-12-10
ATA53492A (de) 1998-05-15
IL101244A0 (en) 1992-11-15
DK0504760T3 (da) 1996-12-23
IE920839A1 (en) 1992-09-23
DE4208258B4 (de) 2007-07-12
LU88087A1 (fr) 1993-10-27
DE4208258A1 (de) 1992-09-24
SK279576B6 (sk) 1999-01-11
ZA921987B (en) 1993-09-20
AT404553B (de) 1998-12-28
NO310754B1 (no) 2001-08-27
GB2253853B (en) 1995-04-26
GR3021497T3 (en) 1997-01-31
IL101244A (en) 1996-10-31
AU658172B2 (en) 1995-04-06
GB2253853A (en) 1992-09-23
GB9205554D0 (en) 1992-04-29
ITRM920181A0 (it) 1992-03-17
NO921012D0 (no) 1992-03-16
GB9105705D0 (en) 1991-05-01
HUT61324A (en) 1992-12-28
EP0504760A1 (en) 1992-09-23
FI921125L (fi) 1992-09-19
ITRM920181A1 (it) 1993-09-17
EP0504760B1 (en) 1996-10-09
MX9201141A (es) 1992-10-01
SA92120536B1 (ar) 2005-04-27
CA2063106A1 (en) 1992-09-19
KR920017644A (ko) 1992-10-21
CH685229A5 (de) 1995-05-15
ES2093130T3 (es) 1996-12-16
FI921125A7 (fi) 1992-09-19
NZ241975A (en) 1994-04-27
US5719123A (en) 1998-02-17
TW215901B (cg-RX-API-DMAC7.html) 1993-11-11
CZ281260B6 (cs) 1996-07-17
HU9200735D0 (en) 1992-05-28
FI921125A0 (fi) 1992-03-16
CA2063106C (en) 2002-12-17
FR2674249A1 (fr) 1992-09-25
NO921012L (no) 1992-09-21
CS78592A3 (en) 1992-10-14
IT1255040B (it) 1995-10-13

Similar Documents

Publication Publication Date Title
JP2549794B2 (ja) 肺投与用のシクロスポリン形態
DE69631881T2 (de) Pulmonale verabreichung von medikamenten in aerosolform
EP3246016B1 (en) Dry powder formulation comprising a phosphodiesterase inhibitor
US8182791B2 (en) Formulations for use in inhaler devices
US8871274B2 (en) Pharmaceutical formulations for dry powder inhalers
Yang et al. Recent developments in dry powder inhalation (DPI) formulations for lung-targeted drug delivery
EP0964675B1 (en) Dry powder inhaler excipient, process for its preparation and pharmaceutical compositions containing it
JP2025090573A (ja) 吸入のためのｇｍ－ｃｓｆの液体製剤
Malamatari Inhaled theophylline: old drug new tricks?
US20080292713A1 (en) Respirable Powders
CN102846633B (zh) 含有n-乙酰-l-半胱氨酸和环索奈德的吸入制剂及其制备方法
JP2001072586A (ja) 吸入用粉末製剤及びその製造方法
KR20070110418A (ko) 입자 및 그 입자를 함유하는 제제